Matthew Chu

Matthew Chu has extensive experience in the pharmaceutical and biotechnology industry, currently serving as Director of Pricing, Contracting, and Distribution - Market Access at Genentech since June 2016. In this role, Matthew leads strategies for a $4B+ product franchise, focusing on market access in various therapeutic areas, including Immunology and Nephrology. Previous positions at Genentech include Director of Account Strategy and Negotiations, where Matthew managed customer strategies for an $8B portfolio, and Senior Marketing Manager for the Immunology Franchise. Over the years, Matthew has demonstrated expertise in market research, pricing, and strategic planning, having also worked at companies such as MC10 Inc., Target, ZS Associates, and Cedars-Sinai Medical Center. Matthew holds an M.B.A. from Harvard Business School and a BSE in Bioengineering from the University of Pennsylvania.